ASEPA EXCLUSIVE WEBINARS:
* The information presented in these webinars are for education purposes. They are intended for U.S. licensed healthcare professionals. They are not intended to substitute for professional medical advice. Speakers cannot provide individual medical advice during these programs. Patients should discuss treatment options with their healthcare provider to find the best option for them.​​​​​
​
​​
​​
*Unless otherwise noted, all webinars are at 8 PM EST​​​​​​​​​​​​​
​​
​
-
December 3, 2025 - Evolution of GLP-1 Receptor Agonists: Indications and Clinical Benefits to Patients with Chronic Cardiometabolic Disease by Richard Easom, PhD with Novo Nordisk
Zoom link: https://us02web.zoom.us/j/89798152704
UPCOMING WEBINARS:
PREVIOUS WEBINARS:
-
November 2025 - Expert Tips on Evaluating Thyroid Nodules by Chris Sadler, PA-C, CDCES, DFAAPA
-
October 2025 - CRYSVITA® (burosumab-twza): Targeted Treatment for Adults With X-Linked Hypophosphatemia (XLH) by Jacqi Kernaghan, MS, PA-C, DFAAPA
-
September 2025 - Diagnosis and Management of Hyperglycemic Crises in Adults by Heidi Webb, MMS, PA-C, CAQ-HM
- Enduring CME evaluation​
-
August 2025 - Treatment of Hypercortisolism in People with Difficult-to-Control Type 2 Diabetes - Final Results of the CATALYST Trial by CJ Chun, PA-C, MPAS, BC-ADM
-
July 2025 - MASLD/MASH Review by Anesia Reticker, PharmD, BCTXP
-
June 2025 - Pediatric Endocrinology for Adult Endocrinology Providers: Bridging the Gap in Shared Endocrine Conditions by Jesse Lyon, PA-C
- Enduring CME evaluation
-
May 2025 - What is happening with ASEPA? Updates from the President by Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES (non-CME)
-
April 2025 - Helping People with Diabetes Thrive with Time in Range by Audree Hall, BA with diaTribe (non-CME)
-
March 2025 - Secondary Causes of Osteoporosis by Jacqui Kernaghan, MS, PA-C, DFAAPA
(*Sequel to February 2024 Webinar "Osteoporosis")
- Enduring CME evaluation
-
February 2025 - Resolving Diagnostic Uncertainty with ThyGeNEXT + ThyraMIRv2 Molecular Testing for Indeterminate Thyroid Nodules by Ashley W. Akers, PA-C, MMSc (non-CME)
-
​January 2025 - dStigmatizing Diabetes by Shae Puckett, M.S. (non-CME)
-
​December 2024 - Prevalence of Hypercortisolism in Difficult-to-treat Diabetes: Preliminary Results from CATALYST Part 1 by CJ Chun, PA-C and Dr. Dan Einhorn, MD (non-CME)
-
November 2024 - Hypophosphatasia Review by Jacqui Kernaghan, MS, PA-C, DFAAPA (non-CME)
-
October 2024 - An Update On Finerenone Beyond CKD and Type 2 DM by Maria O'Connor, PA-C, RD, CDCES (non-CME)
-
September 2024 - ASEPA Case Studies: Clinical cases of Type 3c Diabetes and MODY by Katharine Patrick, MMSc, PA-C and Amy Hess Fischl, MS, RDN, LDN, BC-ADM, CDCES
​ - Enduring CME evaluation
-
August 2024- Celiac Disease by Alyssa Greenleaf, MHS, PA-C
- Enduring CME evaluation​
- Enduring CME evaluation​
-
​June 2024- Bempedoic Acid by Michelle Lim, PA-C (non-CME)​
-
May 2024- Cardiometabolic Health Congress Certification by Robert Eckel, MD (non-CME)
-
April 2024- Immune Checkpoint Inhibitors by Justine Herndon, PA-C
- Enduring CME evaluation​
-
​March 2024- BD-ADM Certification by Chris Memering, CDCES (non-CME)​
-
February 2024- Osteoporosis by Jacqui Kernaghan, MS, PA-C, DFAAPA
-
January 2024- An update on the June 2023 Adrenal Incidentaloma Guidelines by CJ Chun, PA-C (non- CME)
-
December 2023- Endocrine Work-up of Obesity ​
-
November 2023 - Obesity Pathogenesis & Treatment
- Enduring CME evaluation
-
October 2023 - PA Professional Development Panel Discussion (non-CME)
-
September 2023 - Tzield (non-CME)
-
August 2023 - Endocrine Hypertension
-
July 2023 - SGLT2 inhibitors
-
June 2023 - PTH-mediated Hypercalcemia
-
May 2023 - Diabetes Technology
-
April 2023 - Dexcom (non-CME ) (video unavailable)
-
March 2023 - PANRE Alternative
-
February 2023 - Afrezza (non-CME) (video unavailable)
-
January 2023 - no webinar​
​
​
2022 Webinars:
-
December 2022 - Updates and Tips for Success Using FS Libre 2 and 3 (non-CME)
-
November 2022 - Pheochromocytomas and Paragangliomas
-
October 2022 - Tandem Pumps and T connect reports
-
September 2022 - Mounjaro (non-CME) (video unavailable)
-
August 2022 - Wegovy (non-CME) and OmniPod 5 (non-CME)
-
July 2022 - Hypercalcemia of Malignancy
-
June 2022 - no webinar
-
May 2022 - Central Hyperthyroidism
-
April 2022 - Slowing the Development of Autoimmune Diabetes (video unavailable)
-
March 2022 - Gender Affirming Hormone Therapy: The Basics and Beyond - Troubleshooting Complications and Hot Topics
-
Feb 2022 - Dexcom Connected Ecosystems and Partnerships
-
January 2022 - no webinar
​
2021 Webinars:
​
-
Dec 2021 - Omega-3 fatty acids and hypertriglyceridemia
-
Oct 2021 - Pituitary Tumor Series Part 1 - Workup of Sellar Masses
-
Sept 2021 - Gvoke: Treatment of Severe Hypoglycemia
-
August 2021 - Management of Type 1 DM in pregnancy
-
July 2021 - Acromegaly
-
June 2021 - Cushing's Syndrome
-
May 2021 - SGLT2i in setting of DM and CKD (non-CME)
-
April 2021 - Osteoporosis
-
March 2021 - Adrenal Incidenalomas (non-CME)
-
Feb 2021 - PAs and Clinical Research
-
Jan 2021 - V-go
​
2020 Webinars:
​
-
Dec 2020 - CGM Therapy - What's New
​
​​​
2019 Webinars:
​
-
Nov 2019 - Using CGM Data Effectively
​
​